Zobrazeno 1 - 10 of 495 pro vyhledávání: '"Chand AL"'
1
Akademický článek
DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression.
Autor: Afshar-Sterle S; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Carli ALE; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., O'Keefe R; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Tse J; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Fischer S; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Azimpour AI; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Baloyan D; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Elias L; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Thilakasiri P; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Patel O; ACRF Chemical Biology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Ferguson FM; Department of Chemistry and Biochemistry and the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA., Eissmann MF; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Chand AL; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Gray NS; Department of Chemical and Systems Biology, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Busuttil R; Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Gastroenterology, Alfred Hospital, Melbourne, VIC, Australia., Boussioutas A; Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Gastroenterology, Alfred Hospital, Melbourne, VIC, Australia., Lucet IS; ACRF Chemical Biology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Ernst M; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Buchert M; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.
Publikováno v: Science signaling [Sci Signal] 2024 Sep 17; Vol. 17 (854), pp. eabq4888. Date of Electronic Publication: 2024 Sep 17.
Zobrazit plný text záznamu
2
Akademický článek
Ehf controls mammary alveolar lineage differentiation and is a putative suppressor of breast tumorigenesis.
Autor: Nightingale R; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Reehorst CM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Vukelic N; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Papadopoulos N; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Liao Y; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Guleria S; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Bell C; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Vaillant F; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3052, Australia., Paul S; Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia; Baker Department of Cardiovascular Research Translation and Implementation, La Trobe University, Bundoora, VIC 3086, Australia., Luk IY; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Dhillon AS; The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC 3220, Australia., Jenkins LJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Morrow RJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Jackling FC; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute, Parkville, VIC 3052, Australia., Chand AL; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Chisanga D; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Chen Y; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3052, Australia; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Williams DS; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia; Department of Pathology, Austin Health, Heidelberg, VIC 3084, Australia., Anderson RL; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia., Ellis S; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Meikle PJ; Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia; Baker Department of Cardiovascular Research Translation and Implementation, La Trobe University, Bundoora, VIC 3086, Australia., Shi W; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia., Visvader JE; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3052, Australia., Pal B; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia. Electronic address: bhupinder.pal@onjcri.org.au., Mariadason JM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia; Department of Medicine, University of Melbourne, Parkville, VIC 3052, Australia. Electronic address: john.mariadason@onjcri.org.au.
Publikováno v: Developmental cell [Dev Cell] 2024 Aug 05; Vol. 59 (15), pp. 1988-2004.e11. Date of Electronic Publication: 2024 May 22.
Zobrazit plný text záznamu
3
Akademický článek
Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer.
Autor: Dmello RS; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia., Palmieri M; Walter and Eliza Hall Institute of Medical Research (WEHI), Parkville, VIC, 3010, Australia., Thilakasiri PS; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia., Doughty L; Department of Biochemistry and Pharmacology, and ACRF Facility for Innovative Cancer Drug Discovery, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, 3010, Australia., Nero TL; Department of Biochemistry and Pharmacology, and ACRF Facility for Innovative Cancer Drug Discovery, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, 3010, Australia., Poh AR; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia., To SQ; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia., Lee EF; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.; Department of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, 3083, Australia., Douglas Fairlie W; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia.; Department of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, 3083, Australia., Mielke L; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia., Parker MW; Department of Biochemistry and Pharmacology, and ACRF Facility for Innovative Cancer Drug Discovery, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, 3010, Australia.; ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, VIC, 3065, Australia., Poon IKH; Department of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, 3083, Australia., Batlle E; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Spain., Ernst M; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia., Chand AL; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia. ashwini.chand@onjcri.org.au.
Publikováno v: Cell death & disease [Cell Death Dis] 2024 Apr 10; Vol. 15 (4), pp. 255. Date of Electronic Publication: 2024 Apr 10.
Zobrazit plný text záznamu
4
Akademický článek
Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3.
Autor: Thilakasiri P; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., O'Keefe RN; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., To SQ; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., Chisanga D; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., Eissmann MF; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., Carli AL; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., Duscio B; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., Baloyan D; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., Dmello RS; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., Williams D; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia.; Department of Pathology, Austin Health, Heidelberg, Australia., Mariadason J; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., Poh AR; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., Pal B; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., Kile BT; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia., Vissers JH; Peter MacCallum Cancer Centre, Melbourne, Australia., Harvey KF; Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Anatomy and Developmental Biology, and Biomedicine Discovery Institute, Monash University, Clayton, Australia., Buchert M; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., Shi W; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia., Ernst M; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia matthias.ernst@onjcri.org.au., Chand AL; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Australia ashwini.chand@onjcri.org.au.
Publikováno v: Life science alliance [Life Sci Alliance] 2023 Nov 13; Vol. 7 (2). Date of Electronic Publication: 2023 Nov 13 (Print Publication: 2024).
Zobrazit plný text záznamu
5
Akademický článek
Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy.
Autor: Poh AR; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria 3084, Australia., Love CG; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Chisanga D; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria 3084, Australia., Steer JH; School of Biomedical Sciences, University of Western Australia, Crawley, Western Australia 6009, Australia., Baloyan D; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria 3084, Australia., Chopin M; Walter and Eliza Hall Institute and Department of Medical Biology, University of Melbourne, Melbourne, Victoria 3052, Australia., Nutt S; Walter and Eliza Hall Institute and Department of Medical Biology, University of Melbourne, Melbourne, Victoria 3052, Australia., Rautela J; Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3186, Australia.; oNKo-Innate Pty Ltd, Moonee Ponds, Victoria 3039, Australia., Huntington ND; Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3186, Australia.; oNKo-Innate Pty Ltd, Moonee Ponds, Victoria 3039, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3186, Australia., Etemadi N; Walter and Eliza Hall Institute and Department of Medical Biology, University of Melbourne, Melbourne, Victoria 3052, Australia., O'Brien M; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria 3084, Australia., O'Keefe R; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria 3084, Australia., Ellies LG; School of Biomedical Sciences, University of Western Australia, Crawley, Western Australia 6009, Australia., Macri C; Department of Biochemistry and Pharmacology, University of Melbourne and Bio21 Molecular Science and Biotechnology Institute, Melbourne, Victoria 3010, Australia., Mintern JD; Department of Biochemistry and Pharmacology, University of Melbourne and Bio21 Molecular Science and Biotechnology Institute, Melbourne, Victoria 3010, Australia., Whitehead L; Walter and Eliza Hall Institute and Department of Medical Biology, University of Melbourne, Melbourne, Victoria 3052, Australia., Gangadhara G; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria 3084, Australia., Boon L; JJP Biologics, Warsaw, Poland., Chand AL; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria 3084, Australia., Lowell CA; University of California, San Francisco, San Francisco, CA 94131, USA., Shi W; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria 3084, Australia., Pixley FJ; School of Biomedical Sciences, University of Western Australia, Crawley, Western Australia 6009, Australia., Ernst M; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria 3084, Australia.
Publikováno v: Science advances [Sci Adv] 2022 Jun 24; Vol. 8 (25), pp. eabl7882. Date of Electronic Publication: 2022 Jun 22.
Zobrazit plný text záznamu
6
Akademický článek
STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential.
Autor: To SQ; Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Heidelberg, VIC 3084, Australia., Dmello RS; Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Heidelberg, VIC 3084, Australia., Richards AK; Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Heidelberg, VIC 3084, Australia., Ernst M; Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Heidelberg, VIC 3084, Australia., Chand AL; Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Heidelberg, VIC 3084, Australia.
Publikováno v: Cancers [Cancers (Basel)] 2022 Jan 15; Vol. 14 (2). Date of Electronic Publication: 2022 Jan 15.
Zobrazit plný text záznamu
7
Akademický článek
Host IL11 Signaling Suppresses CD4 + T cell-Mediated Antitumor Responses to Colon Cancer in Mice.
Autor: Huynh J; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Baloyan D; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Chisanga D; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Shi W; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., O'Brien M; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Afshar-Sterle S; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Alorro M; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Pang L; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Williams DS; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia.; Department of Pathology, Austin Health, Heidelberg, Victoria, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia., Parslow AC; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Thilakasiri P; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Eissmann MF; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Boon L; Polpharma Biologics, Utrecht, the Netherlands., Masson F; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Chand AL; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia., Ernst M; Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia. matthias.ernst@onjcri.org.au.
Publikováno v: Cancer immunology research [Cancer Immunol Res] 2021 Jul; Vol. 9 (7), pp. 735-747. Date of Electronic Publication: 2021 Apr 27.
Zobrazit plný text záznamu
8
Akademický článek
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.
Autor: Liu, Shan1 (AUTHOR), Zhang, Xingda1 (AUTHOR), Wang, Wenzheng1 (AUTHOR), Li, Xue1 (AUTHOR), Sun, Xue1 (AUTHOR), Zhao, Yuqian1 (AUTHOR), Wang, Qi1 (AUTHOR), Li, Yingpu1 (AUTHOR) liyingpu@hrbmu.edu.cn, Hu, Fangjie2 (AUTHOR) 18846419361@163.com, Ren, He1 (AUTHOR) renhe@hrbmu.edu.cn
Publikováno v: Molecular Cancer. 11/21/2024, Vol. 23 Issue 1, p1-57. 57p.
Zobrazit plný text záznamu
9
Akademický článek
Adipose stem cell exosomes, stimulated by pro-inflammatory factors, enhance immune evasion in triple-negative breast cancer by modulating the HDAC6/STAT3/PD-L1 pathway through the transporter UCHL1.
Autor: Zhu, Qin1 (AUTHOR), Zhang, Kejing1 (AUTHOR), Cao, Yukun1 (AUTHOR), Hu, Yu1 (AUTHOR) huyula99@163.com
Publikováno v: Cancer Cell International. 11/20/2024, Vol. 24 Issue 1, p1-19. 19p.
Zobrazit plný text záznamu
10
Akademický článek
Identification of novel variants and candidate genes in women with 46,XX complete gonadal dysgenesis.
Autor: Ding, Leilei1 (AUTHOR), Deng, Shan1 (AUTHOR), Zhang, Pan1 (AUTHOR), Zhang, Duoduo1 (AUTHOR), Tian, Qinjie1,2 (AUTHOR) qinjietn@163.com
Publikováno v: Reproductive Biology & Endocrinology. 11/11/2024, Vol. 22 Issue 1, p1-8. 8p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje